FREE webinar 👩🏼💻 Secrets to Successful Glycemic Programs.

Goal Range Effect on Hypoglycemia Incidence for Intravenous Insulin Dosing
Objective
This retrospective study examines the effect of goal range on incidence of hypoglycemia in patients receiving intravenous insulin therapy (managed with EndoTool).
Setting
Cohort of five unaffiliated acute care hospitals.
Results
- Incidence of hypoglycemia <70 mg/dL was 35.5% lower with a goal range of 160-200 mg/dL goal range than a goal range of 100-140 mg/dL (0.22% vs 0.34% of blood glucose readings).
- Whereas 73% of hypoglycemia events occurred following a blood glucose <120 mg/dL, 27% occurred following a blood glucose >120 mg/dL.
Conclusions
With use of EndoTool to manage intravenous insulin therapy, incidence of hypoglycemia may likely decrease by reducing the overall goal range spread concurrent to reducing the upper limit.
Authors
Anderson Schrader; W. Patrick Burgess; Laurel Fuqua.
Source
Presented at American Association of Clinical Endocrinologists Scientific & Clinical Congress.
Year
2019
Tags
- Cost Savings
- Healthcare-Associated Infections
- Hospital-Acquired Conditions
- Hyperglycemia Reduction
- Hypoglycemia Reduction
- Length of Stay
- Surgical Site Infections
- Glucose Variability
- Mean Glucose Improvement
- Target Goal Attainment
- Time in Range
- Time on IV Insulin
- Time to Target
- Burn Injury
- Cardiac Surgery
- DKA/HHS Management
- Emergency Department
- Induced Hypothermia
- Intra-op Glucose Management
- Obstetrics/Labor & Delivery
- Pediatrics
- Residual Insulin Adjustment
- BG Check Compliance
- BG Test Reduction
- Nursing Satisfaction
- Protocol Adherence
- Provider Satisfaction
- Workflow Improvements